These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 29863982

  • 1. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
    Nam EY, Yang SJ, Kim ES, Cho JE, Park KH, Jung SI, Yoon N, Kim DM, Lee CS, Jang HC, Park Y, Lee KS, Kwak YG, Lee JH, Park SY, Hwang JH, Kim M, Song KH, Kim HB.
    Microb Drug Resist; 2018 Jun; 24(5):534-541. PubMed ID: 29863982
    [Abstract] [Full Text] [Related]

  • 2. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I, Fujisaki S, Aiba Y, Watanabe S, Mikawa T, Katsuse AK, Takahashi H, Cui L, Kobayashi I.
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [Abstract] [Full Text] [Related]

  • 3. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A, Cafiso V, Campanile F, Parisi G, Mariani B, Petrosillo N, Stefani S.
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [Abstract] [Full Text] [Related]

  • 4. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K, Aiba Y, Tan XE, Watanabe S, Kiga K, Sato'o Y, Boonsiri T, Li FY, Sasahara T, Taki Y, Azam AH, Zhang Y, Cui L.
    Sci Rep; 2020 Sep 30; 10(1):16107. PubMed ID: 32999359
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM, Mishra NN, Park KT, Lee GY, Park YH, Bayer AS, Yang SJ.
    J Microbiol; 2017 Feb 30; 55(2):153-159. PubMed ID: 28120188
    [Abstract] [Full Text] [Related]

  • 6. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.
    Bertsche U, Yang SJ, Kuehner D, Wanner S, Mishra NN, Roth T, Nega M, Schneider A, Mayer C, Grau T, Bayer AS, Weidenmaier C.
    PLoS One; 2013 Feb 30; 8(6):e67398. PubMed ID: 23785522
    [Abstract] [Full Text] [Related]

  • 7. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR, Barber KE, Hallesy J, Raut A, Rybak MJ.
    Antimicrob Agents Chemother; 2015 Sep 30; 59(9):5529-34. PubMed ID: 26124162
    [Abstract] [Full Text] [Related]

  • 8. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Infection.
    Taglialegna A, Varela MC, Rosato RR, Rosato AE.
    mSphere; 2019 Feb 13; 4(1):. PubMed ID: 30760612
    [Abstract] [Full Text] [Related]

  • 9. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
    Bayer AS, Mishra NN, Chen L, Kreiswirth BN, Rubio A, Yang SJ.
    Antimicrob Agents Chemother; 2015 Aug 13; 59(8):4930-7. PubMed ID: 26055370
    [Abstract] [Full Text] [Related]

  • 10. dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus.
    Cafiso V, Bertuccio T, Purrello S, Campanile F, Mammina C, Sartor A, Raglio A, Stefani S.
    Int J Antimicrob Agents; 2014 Jan 13; 43(1):26-31. PubMed ID: 24183798
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Barber KE, Smith JR, Ireland CE, Boles BR, Rose WE, Rybak MJ.
    Antimicrob Agents Chemother; 2015 Aug 13; 59(8):4497-503. PubMed ID: 25987623
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus.
    Iwata Y, Satou K, Tsuzuku H, Furuichi K, Senda Y, Sakai-Takemori Y, Wada T, Fujita S, Miyake T, Yasuda H, Sakai N, Kitajima S, Toyama T, Shinozaki Y, Sagara A, Miyagawa T, Hara A, Shimizu M, Kamikawa Y, Kaneko S, Wada T.
    Eur J Clin Microbiol Infect Dis; 2017 Oct 13; 36(10):1839-1845. PubMed ID: 28477235
    [Abstract] [Full Text] [Related]

  • 13. Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.
    Xiong YQ, Hady WA, Bayer AS, Chen L, Kreiswirth BN, Yang SJ.
    Antimicrob Agents Chemother; 2012 Nov 13; 56(11):5528-33. PubMed ID: 22890759
    [Abstract] [Full Text] [Related]

  • 14. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
    Mishra NN, Yang SJ, Chen L, Muller C, Saleh-Mghir A, Kuhn S, Peschel A, Yeaman MR, Nast CC, Kreiswirth BN, Crémieux AC, Bayer AS.
    PLoS One; 2013 Nov 13; 8(8):e71151. PubMed ID: 23990934
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.
    Bayer AS, Mishra NN, Sakoulas G, Nonejuie P, Nast CC, Pogliano J, Chen KT, Ellison SN, Yeaman MR, Yang SJ.
    Antimicrob Agents Chemother; 2014 Dec 13; 58(12):7462-7. PubMed ID: 25288091
    [Abstract] [Full Text] [Related]

  • 16. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
    Mirza HC, Sancak B, Gür D.
    Microb Drug Resist; 2015 Oct 13; 21(5):537-44. PubMed ID: 25919019
    [Abstract] [Full Text] [Related]

  • 17. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms.
    Yang SJ, Nast CC, Mishra NN, Yeaman MR, Fey PD, Bayer AS.
    Antimicrob Agents Chemother; 2010 Aug 13; 54(8):3079-85. PubMed ID: 20498310
    [Abstract] [Full Text] [Related]

  • 18. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
    Mehta S, Singh C, Plata KB, Chanda PK, Paul A, Riosa S, Rosato RR, Rosato AE.
    Antimicrob Agents Chemother; 2012 Dec 13; 56(12):6192-200. PubMed ID: 22985884
    [Abstract] [Full Text] [Related]

  • 19. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.
    Mehta S, Cuirolo AX, Plata KB, Riosa S, Silverman JA, Rubio A, Rosato RR, Rosato AE.
    Antimicrob Agents Chemother; 2012 Jan 13; 56(1):92-102. PubMed ID: 21986832
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.